Stephen L. Holcombe
2017
In 2017, Stephen L. Holcombe earned a total compensation of $1.2M as President and Chief Executive Officer at vTv Therapeutics, a 83% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $95,625 |
|---|---|
| Option Awards | $691,516 |
| Salary | $450,000 |
| Other | $8,721 |
| Total | $1,245,862 |
Holcombe received $691.5K in option awards, accounting for 56% of the total pay in 2017.
Holcombe also received $95.6K in non-equity incentive plan, $450K in salary and $8.7K in other compensation.
Rankings
In 2017, Stephen L. Holcombe's compensation ranked 7,925th out of 14,666 executives tracked by ExecPay. In other words, Holcombe earned more than 46.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,925 out of 14,666 | 46th |
Division Manufacturing | 2,972 out of 5,768 | 49th |
Major group Chemicals And Allied Products | 972 out of 2,074 | 53rd |
Industry group Drugs | 758 out of 1,730 | 56th |
Industry Pharmaceutical Preparations | 595 out of 1,329 | 55th |
Source: SEC filing on March 16, 2018.
Holcombe's colleagues
We found three more compensation records of executives who worked with Stephen L. Holcombe at vTv Therapeutics in 2017.
News
vTv Therapeutics CEO Deepa Prasad receives $3.3M in 2021
May 2, 2022
vTv Therapeutics CEO Stephen Holcombe's 2020 pay jumps 68% to $1.4M
March 18, 2021
vTv Therapeutics CEO Stephen Holcombe's 2019 pay jumps 81% to $833K
April 30, 2020
vTv Therapeutics CEO Stephen Holcombe's 2018 pay falls 63% to $459K
March 15, 2019